x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

PETRI DISH PERSPECTIVES

Burma | ChicagoScientist 🥼🧪🔬Covering biotech, pharma, and healthcare companies shaping the world 🧬🏥🌎Stream new episodes every THURSDAY!https://linktr.ee/maneadkhin#biotech #pharma #healthcare #podcast #petridishperspectives

science life sciences

All Episodes

23:38

Episode 27: Tempus AI

PETRI DISH PERSPECTIVES ·

2025/10/31

Send us a text What if the cure for cancer or the key to mental health, wasn’t hidden in a new drug, but in data itself? In this episode of Petri Dish Perspectives, we uncover the story of Tempus AI, the company turning raw medical information into lifesaving insight. Founded by Eric Lefkofsky, the entrepreneur behind Groupon, Tempus began as a deeply personal mission to bring clarity to cancer care. Today, it’s one of the most advanced AI-driven healthcare platforms in the world, combining g...

en-us

23:42

Episode 26: Wuxi AppTec

PETRI DISH PERSPECTIVES ·

2025/10/23

Send us a text What if the secret engine driving modern drug discovery wasn’t in Boston or Basel, but in Shanghai? In this episode of Petri Dish Perspectives: Biotech Unleashed, host Manead dives deep into the rise of WuXi AppTec, a company that redefined how the world develops medicine. We explore its fascinating journey, from a humble chemistry startup founded by Dr. Ge Li to a global R&D and manufacturing giant that helps nearly every top pharma and biotech company bring therapies to l...

en-us

23:10

Episode 25: CVS Health

PETRI DISH PERSPECTIVES ·

2025/10/16

Send us a text From a small pharmacy in Massachusetts to a $100 billion healthcare empire, CVS Health has redefined what it means to be a pharmacy. In this episode of Petri Dish Perspectives: Biotech Unleashed, host Manead dives into CVS’s fascinating evolution, from its early days as Consumer Value Store to its bold moves acquiring Aetna and transforming into a fully integrated healthcare provider. We explore how CVS blended retail, insurance, and clinical services to build one of the most p...

en-us

23:18

Episode 24: GLP-1 Agonists

PETRI DISH PERSPECTIVES ·

2025/10/09

Send us a text From a lizard’s venom to Hollywood’s favorite weight-loss trend, this episode of Petri Dish Perspectives: Biotech Unleashed dives deep into the fascinating journey of GLP-1 agonists. Discover how scientists uncovered a gut hormone that revolutionized diabetes care, led to the creation of Ozempic and Mounjaro, and sparked a cultural movement around body image and health. We’ll trace the science, the breakthroughs, and the billion-dollar race shaping the future of metabolic...

en-us

23:30

Episode 23: Alnylam

PETRI DISH PERSPECTIVES ·

2025/10/02

Send us a text What if you could silence disease at its genetic root? That was the bold promise behind RNA interference (RNAi), one of the most groundbreaking scientific discoveries of the 21st century. In this episode, we dive into the story of Alnylam Pharmaceuticals, from its founding by a powerhouse team of Nobel laureates, pioneering scientists, and biotech visionaries, to its transformation into the world’s first RNAi therapeutics company. We explore the challenges of turning a fragile ...

en-us

24:06

Episode 22: Takeda

PETRI DISH PERSPECTIVES ·

2025/09/25

Send us a text From its humble beginnings in 1781 as a family-run herbal medicine shop in Osaka to becoming one of the world’s top 10 pharmaceutical companies, Takeda’s story is one of resilience, reinvention, and bold transformation. In this episode of Petri Dish Perspectives: Biotech Unleashed, host Manead unpacks Takeda’s 240-year journey, from the vision of founder Chobei Takeda, through the blockbuster eras of Prevacid and Actos, to the game-changing acquisition of Shire under CEO Christ...

en-us

24:38

Episode 21: Moderna

PETRI DISH PERSPECTIVES ·

2025/09/18

Send us a text From secrecy and skepticism to one of the fastest vaccine rollouts in history, this episode of Petri Dish Perspectives: Biotech Unleashed dives into the remarkable journey of Moderna. We trace the company’s early hype, billion-dollar partnerships, and criticism for overpromising, through to its historic COVID-19 vaccine that changed global medicine. What’s next for Moderna beyond the pandemic? Tune in to explore how one biotech bet on mRNA and won. Whether you’re a biotech enth...

en-us

23:06

Episode 20: Baxter

PETRI DISH PERSPECTIVES ·

2025/09/11

Send us a text Baxter may not always grab the biotech headlines, but its impact on modern healthcare is impossible to ignore. From the first commercially prepared IV solutions in the 1930s to pioneering dialysis fluids, blood systems, recombinant hemophilia therapies, and parenteral nutrition, Baxter has consistently solved medicine’s “unsexy but essential” problems. In this episode, we dive into the company’s origins, explore the backstories of its most important innovations, and trace how i...

en-us

23:09

Episode 19: AstraZeneca

PETRI DISH PERSPECTIVES ·

2025/09/04

Send us a text In this episode of Petri Dish Perspectives: Biotech Unleashed, host Manead explores the remarkable journey of AstraZeneca, from its unlikely Swedish-British merger to blockbuster drugs like Nexium and Crestor, through near-decline, and ultimately its reinvention as a science-driven leader in oncology, cardiometabolic health, and global public health. Discover how bold leadership, high-risk bets, and groundbreaking discoveries like Tagrisso, Enhertu, and Farxiga transforme...

en-us

24:43

Episode 18: Gilead Sciences

PETRI DISH PERSPECTIVES ·

2025/08/28

Send us a text In this episode of Petri Dish Perspectives: Biotech Unleashed, we dive into the remarkable and controversial story of Gilead Sciences, a company that redefined what medicine could achieve. From its beginnings in the late 1980s under physician-scientist Michael Riordan, Gilead transformed antiviral drug development with breakthroughs in HIV treatment, revolutionized global health with a cure for hepatitis C, and pushed into oncology with cutting-edge CAR-T therapies. But alongsi...

en-us

24:22

Episode 17: GSK

PETRI DISH PERSPECTIVES ·

2025/08/21

Send us a text In this episode of Petri Dish Perspectives: Biotech Unleashed, we dive into the story of GlaxoSmithKline (GSK), one of the world’s most influential pharma giants! From scaling up penicillin production in WWII, to pioneering semi-synthetic antibiotics like amoxicillin, to leading the global vaccine race with Cervarix and Shingrix, GSK has left an indelible mark on modern medicine. We also explore its groundbreaking role in HIV treatment through ViiV Healthcare, and the blockbust...

en-us

26:53

Episode 16: Amgen

PETRI DISH PERSPECTIVES ·

2025/08/14

Send us a text In this episode of Petri Dish Perspectives: Biotech Unleashed, we dive deep into the origin story of Amgen, a company that helped turn “biotechnology” from a niche lab concept into a global medical force. We’ll trace Amgen’s unlikely beginnings in 1980, a time when gene splicing was still the stuff of scientific legend and meet the eclectic founding team: George Rathmann, the charismatic chemist-turned-executive; Winston Salser, the UCLA scientist eager to bring basic research ...

en-us

23:24

Episode 15: BGI Genomics

PETRI DISH PERSPECTIVES ·

2025/08/07

Send us a text What happens when one of the world’s most powerful genomics companies rises from a college dorm in China and goes on to challenge the West’s biotech dominance? In this episode of Petri Dish Perspectives: Biotech Unleashed, we unravel the story of BGI Genomics, a company at the intersection of cutting-edge science, national ambition, and global controversy. From decoding the human genome to building the world’s largest sequencing fleet, BGI’s journey is as bold as it is complex....

en-us

24:55

Episode 14: Abbott

PETRI DISH PERSPECTIVES ·

2025/07/31

Send us a text In this episode of Petri Dish Perspectives: Biotech Unleashed, host Manead takes you inside the remarkable story of Abbott Laboratories: a company that doesn’t chase headlines but touches billions of lives every day. From its origins in 1888 as a small Chicago pharmacy mixing precise plant-based pills, Abbott has grown into a global healthcare powerhouse behind life-changing products like the FreeStyle Libre glucose monitor, BinaxNOW COVID-19 tests, Similac baby formula, Ensure...

en-us

23:06

Episode 13: Sarepta Therapeutics

PETRI DISH PERSPECTIVES ·

2025/07/24

Send us a text DISCLAIMER: This is a consistently changing situation. The episode was recorded approximately 4 PM EDT Monday, July 21, 2025. As of 7.40 PM EDT Monday, July 21, 2025 (Source: Sarepta), "Sarepta Therapeutics notified the U.S. FDA of its decision to voluntarily and temporarily pause all shipments of ELEVIDYS (delandistrogene moxeparvovec) for Duchenne muscular dystrophy in the United States, effective close of business Tuesday, July 22, 2025." 🎙️ When Hope Collides with Ris...

en-us

24:55

Episode 12: Vertex

PETRI DISH PERSPECTIVES ·

2025/07/17

Send us a text 🔬✨ From Cystic Fibrosis Breakthroughs to Gene Editing Cures In this episode of Petri Dish Perspectives: Biotech Unleashed, Manead unpacks how Vertex turned cystic fibrosis from a fatal disease into a treatable condition and why they’re now tackling sickle cell, diabetes, and more with CRISPR and stem cell science. Discover how visionary chemists, Nobel-winning gene editors, and patient advocates built one of biotech’s most inspiring success stories, proving that deep science

en-us

26:46

Episode 11: Genentech

PETRI DISH PERSPECTIVES ·

2025/07/10

Send us a text 🧬 From VC to Blockbusters: The Genentech Story In Episode 11 of Petri Dish Perspectives: Biotech Unleashed, host Manead dives into the legendary rise of Genentech, the startup that sparked the biotech revolution. From its humble beginnings in a borrowed lab to pioneering insulin, tPA, Herceptin, and more, learn how Genentech turned recombinant DNA into real-world cures. Discover the bold VC bets, game-changing antibodies, and the Roche acquisition that preserved its

en-us

20:58

Episode 10: Roche

PETRI DISH PERSPECTIVES ·

2025/07/03

Send us a text 💡 From Vitamin C to AI-Driven Diagnostics: Roche’s Legacy Unleashed In this episode of Petri Dish Perspectives: Biotech Unleashed, we explore the extraordinary evolution of Roche, from its origins as a 19th-century Swiss chemical company to becoming a global leader in pharmaceuticals and diagnostics. You’ll hear how Roche launched the world’s first branded vitamin C, pioneered molecular diagnostics with PCR, and laid the groundwork for today’s precision medicine revolution.

en-us

16:01

Episode 9: Bayer

PETRI DISH PERSPECTIVES ·

2025/06/26

Send us a text 🎧 From Dye Pots to Blockbusters: The Bayer Story In this episode of Petri Dish Perspectives: Biotech Unleashed, host Manead takes you on a journey through Bayer’s 160+ year evolution, from its 1863 roots in coal tar dyes to becoming the maker of Aspirin 💊, Xarelto ❤️, and Eylea 👁️. We explore how a dye salesman and a master dyer built a pharma empire, the game-changing invention of Aspirin, blockbuster therapies, the turbulent Monsanto acquisition 🌾⚖️, and the company’s

en-us

14:13

Episode 8: Bristol Myers Squibb

PETRI DISH PERSPECTIVES ·

2025/06/19

Send us a text In this episode of Petri Dish Perspectives: Biotech Unleashed, we journey through the 165+ year saga of Bristol Myers Squibb (BMS) — from 19th-century Brooklyn apothecaries and sparkling laxatives 💊 to cutting-edge CAR-T therapies and checkpoint inhibitors in cancer treatment 🧫🔥. Host Manead, a PhD scientist in cancer biology and analytical chemistry, breaks down: 📜 The parallel founding stories of E.R. Squibb & Sons and Bristol-Myers 🧠 The game-changing 1989 merger t...

en-us

27 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter